
Journal of Medicinal Chemistry p. 2388 - 2409 (2002)
Update date:2022-07-31
Topics:
Bell, Ian M.
Gallicchio, Steven N.
Abrams, Marc
Beese, Lorena S.
Beshore, Douglas C.
Bhimnathwala, Hema
Bogusky, Michael J.
Buser, Carolyn A.
Culberson, J. Christopher
Davide, Joseph
Ellis-Hutchings, Michelle
Fernandes, Christine
Gibbs, Jackson B.
Graham, Samuel L.
Hamilton, Kelly A.
Hartman, George D.
Heimbrook, David C.
Homnick, Carl F.
Huber, Hans E.
Huff, Joel R.
Kassahun, Kelem
Koblan, Kenneth S.
Kohl, Nancy E.
Lobell, Robert B.
Lynch Jr., Joseph J.
Robinson, Ronald
Rodrigues, A. David
Taylor, Jeffrey S.
Walsh, Eileen S.
Williams, Theresa M.
Zartmant, C. Blair
A series of macrocyclic 3-aminopyrrolidinone farnesyltransferase inhibitors (FTIs) has been synthesized. Compared with previously described linear 3-aminopyrrolidinone FTIs such as compound 1, macrocycles such as 49 combined improved pharmacokinetic prope
View MoreHangzhou Eastbiopharm Co.,Ltd.
Contact:+86-571-88931780
Address:Hangzhou,China
Guangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Dalian RSD International Trade Co.,Ltd.(expird)
Contact:86-22-60875058 58610575
Address:Wantong International Areas, Hongqiao District, Tianjin, China.China
Zhejiang Haizhou Pharmaceutical Co., Ltd.
website:https://www.haizhoupharma.com/
Contact:+86-576-88221016
Address:No. 19, Donghai 5th Avenue, Yanhai Industrial Zone, Linhai, Zhejiang, China
Zhejiang Linhai Xinhua Chemicals Factory
Contact:0086-13661858911
Address:Xunqiao Development Zone, Linhai, Zhejiang, China
Doi:10.1016/S0040-4039(00)75660-7
(1966)Doi:10.1002/ejoc.200700819
(2008)Doi:10.1038/213402a0
(1967)Doi:10.1246/cl.2008.430
(2008)Doi:10.1002/ardp.201500015
(2015)Doi:10.1016/j.bmc.2008.09.058
(2009)